Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Makiko Kido-Nakahara Last modified date:2023.11.22

Lecturer / Surgery / Dermatology / Kyushu University Hospital


Papers
1. Tsuji G, Yamamura K, Kawamura K, Kido-Nakahara M, Ito T, Nakahara T., Regulatory Mechanism of the IL-33-IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis, Int J Mol Sci , 24, 19, 14633, 2023.09.
2. Tsuji G, Yumine A, Yamamura K, Takemura M, Kido-Nakahara M, Ito T, Nakahara T., The therapeutic AHR-modulating agent Tapinarof regulates semaphorin 3A expression in human keratinocytes via NRF2, J Invest Dermatol., doi: 10.1016/j.jid.2023.10.002. , 2023.10.
3. Nakahara T, Onozuka D, Nunomura S, Saeki H, Takenaka M, Matsumoto M, Kataoka Y, Fujimoto R, Kaneko S, Morita E, Tanaka A, Saito R, Okano T, Miyagaki T, Aoki N, Nakajima K, Ichiyama S, Kido-Nakahara M, Tonomura K, Nakagawa Y, Tamagawa-Mineoka R, Masuda K, Takeichi T, Akiyama M, Ishiuji Y, Katsuta M, Kinoshita Y, Tateishi C, Yamamoto A, Morita A, Matsuda-Hirose H, Hatano Y, Kawasaki H, Fukushima-Nomura A, Ohtsuki M, Kamiya K, Kabata Y, Abe R, Mitsui H, Kawamura T, Tsuji G, Katoh N, Furue M, Izuhara K., The ability of biomarkers to assess the severity of atopic dermatitis, J Allergy Clin Immunol Glob. , doi: 10.1016/j.jacig.2023.100175. , 2023.09.
4. Seisho Sato, Makiko Nakahara, Koji Kato, Tomohiko Moriyama, Sae Utsumi, Kensuke Sasaki, Takahiro Shima, Hiroaki Miyoshi, Hidetaka Yamamoto, Masutaka Furue, Plasmablastic lymphoma occurring in the vicinity of enterocutaneous fistula in Crohn's disease, J Dermatol , 47, 12, 442-443, 2020.12.
5. Atsushi Fukunaga, Satoshi Fukushima, Hiroaki Iwata, Makiko Nakahara, Rikako Sasaki, Naoko Baba, Hiroshi Matsunaka, Yumi Murakami, Masutaka Furue , Chikako Nishigori , Bioactive substances in the stratum corneum of the epidermis found as indicators of skin damage due to sun exposure, Photodermatol Photoimmunol Photomed , 38, 5, 241-249, 2022.05.
6. Tsuji G, Yamamura K, Kawamura K, Kido-Nakahara M, Ito T, Nakahara T., Novel Therapeutic Targets for the Treatment of Atopic Dermatitis.
, Biomedicines, 11, 5, 1303, 2023.04.
7. Tsuji G, Hashimoto-Hachiya A, Yumine A, Takemura M, Kido-Nakahara M, Ito T, Yamamura K, Nakahara T., PDE4 inhibition by difamilast regulates filaggrin and loricrin expression via keratinocyte proline-rich protein in human keratinocytes.
, J Dermatol Sci., 110, 2, 61, 2023.05.
8. Tanaka Y, Ito T, Kaku-Ito Y, Tanegashima K, Tsuji G, Kido-Nakahara M, Oda Y, Nakahara T., Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma.
, Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma. Tanaka Y, Ito T, Kaku-Ito Y, Tanegashima K, Tsuji G, Kido-Nakahara M, Oda Y, Nakahara T., 9, 1, 54, 2023.02.
9. Nakahara T, Izuhara K, Onozuka D, Saeki H, Nunomura S, Takenaka M, Matsumoto M, Kataoka Y, Fujimoto R, Kaneko S, Morita E, Tanaka A, Hide M, Okano T, Miyagaki T, Aoki N, Nakajima K, Ichiyama S, Kido-Nakahara M, Tonomura K, Nakagawa Y, Tamagawa-Mineoka R, Masuda K, Takeichi T, Akiyama M, Ishiuji Y, Katsuta M, Kinoshita Y, Tateishi C, Yamamoto A, Morita A, Matsuda-Hirose H, Hatano Y, Kawasaki H, Tanese K, Ohtsuki M, Kamiya K, Kabata Y, Abe R, Mitsui H, Kawamura T, Tsuji G, Katoh N, Furue M., Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study).
, Clin Exp Allergy., 53, 2, 233, 2023.02.
10. Kunimura K, Yamamura K, Nakahara T, Kido-Nakahara M, Uruno T, Fukui Y., Identification of a functional DOCK8 gene polymorphism associated with atopic dermatitis.
, Allergy, 77, 7712, 3670, 2022.12.
11. Seisho Sato, Makiko Nakahara , Koji Kato , Tomohiko Moriyama , Sae Utsumi , Kensuke Sasaki , Takahiro Shima, Hiroaki Miyoshi , Hidetaka Yamamoto , Masutaka Furue , Plasmablastic lymphoma occurring in the vicinity of enterocutaneous fistula in Crohn's disease, J Dermatol, 10.1111/1346-8138.15600, 47, e442, 2020.12.
12. Fukunaga A, Fukushima S, Iwata H, Nakahara M, Sasaki R, Baba N, Matsunaka H, Murakami Y, Furue M, Nishigori C., Bioactive substances in the stratum corneum of the epidermis found as indicators of skin damage due to sun exposure., Photodermatol Photoimmunol Photomed. , doi: 10.1111/phpp.1274, 2021.10.
13. Nakahara T, Kido-Nakahara M, Onozuka D, Sakai S, Hirose T, Take N, Sugiyama A, Harada K, Tsuji G, Kikuchi S, Kohda F., Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study., Acta Derm Venereol, doi: 10.2340/actadv.v101.369, 2021.11.
14. Kido-Nakahara M, Yokote G, Yoshida M, Furue M, Nakahara T., Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis., J Dermatol., 48, 12, 1951-1952, 2021.12.
15. Zeze N, Kido-Nakahara M, Tsuji G, Maehara E, Sato Y, Sakai S, Fujishima K, Hashimoto-Hachiya A, Furue M, Nakahara T., Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target., Int J Mol Sci., doi: 10.3390/ijms23073467., 23, 7, 3467, 2022.03.
16. Ulzii D, Nakahara T, Furue M, Byamba K, Kido-Nakahara M., Severity strata of patient-oriented eczema measure scores in patients with atopic dermatitis in Mongolia., Int J Dermatol., doi: 10.1111/ijd.16181, 2022, 2022.02.
17. Kamikaseda Y, Uruno T, Kunimura K, Harada A, Saiki K, Oisaki K, Sakata D, Nakahara T, Kido-Nakahara M, Kanai M, Nakamura S, Ohkawa Y, Furue M, Fukui Y., Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound, J Allergy Clin Immunol., doi: 10.1016/j.jaci.2021.03.029., 2021.04.
18. Nakahara T, Kido-Nakahara M, Tsuji G, Furue M., Basics and recent advances in the pathophysiology of atopic dermatitis., 48, 130, 2021.02.
19. Sagata N, Kano SI, Ohgidani M, Inamine S, Sakai Y, Kato H, Masuda K, Nakahara T, Nakahara-Kido M, Ohga S, Furue M, Sawa A, Kanba S, Kato TA., Forskolin rapidly enhances neuron-like morphological change of directly induced-neuronal cells from neurofibromatosis type 1 patients., Neuropsychopharmacol Rep., 40, 396, 2020.12.
20. Furue K, Ulzii D, Tanaka Y, Ito T, Tsuji G, Kido-Nakahara M, Nakahara T, Furue M., Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis, J Dermatol. , 47, 979, 2020.09.
21. Kido-Nakahara M, Wang B, Ohno F, Tsuji G, Ulzii D, Takemura M, Furue M, Nakahara T, Inhibition of mite-induced dermatitis, pruritus, and nerve sprouting in mice by the endothelin receptor antagonist bosentan., Allergy., doi: 10.1111/all.14451, 76, 1, 291-301, 2021.01, エンドセリンは哺乳類においてかゆみを誘導し、アトピー性皮膚炎患者の皮疹部に高発現している。また、血清エンドセリン値はアトピー性皮膚炎の病勢や痒みの程度と相関することが明らかとなっている。そこで、我々は、エンドセリンがアトピー性皮膚炎の治療ターゲットになりうるのではないかと考え、マウスアトピー性皮膚炎モデルやマウス後根神経節を用いて検証した。エンドセリン受容体阻害薬(ボセンタン)をマウスアトピー性皮膚炎モデルの皮疹部に外用すると、皮膚の炎症や痒み、表皮内の神経伸張を有意に抑制した。一方、エンドセリンはかゆみを伝達に関与するマウス後根神経節細胞の神経を伸張させ、またボセンタンはその神経伸張を抑制した。以上より、エンドセリンは、マウスアトピー性皮膚炎の炎症や痒みに重要な役割を持っており、エンドセリン受容体拮抗薬はアトピー性皮膚炎の治療薬として有望な候補となりうると考えられる。.
22. Nakahara T, Kido-Nakahara M, Ulzii D, Miake S, Fujishima K, Sakai S, Chiba T, Tsuji G, Furue M., Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation, Sci Rep. , 10, 9510, 2020.06.
23. Makiko Kido-Nakahara, Takeshi Nakahara, Yumi Yasukochi, Dugarmaa Ulzii, Masutaka Furue, Patient-Oriented Eczema Measure Score: A Useful Tool for Web-Based Surveys in Patients With Atopic Dermatitis , Acta Derm Venereol , doi: 10.2340/00015555-3530, 2020.05.
24. Eto A, Nakahara T, Kido-Nakahara M, Tsuji G, Furue M, Acrosyringeal endothelin-1 Expression: Potential for Fostering Melanocytes in Volar Sites , J Dermatol. , doi: 10.1111/1346-8138.15404. , 2020.05.
25. Kido-Nakahara M, Nakahara T, Yasukochi Y, Ulzii D, Furue M. , Patient-Oriented Eczema Measure score: A Useful Tool for Web-Based Surveys in Patients with Atopic Dermatitis., Acta Derm Venereol, 100, 2020.05.
26. Furue K, Ito T, Tsuji G, Esaki H, Kido-Nakahara M, Nakahara T, Furue M., Does mechanical scratching cause the recruitment of T-helper 17 cells in atopic dermatitis?, J Dermatol, 46(11):e436-e437, 2019.11.
27. Yano-Takamori A, Tsuji G, Nakahara T, Kido-Nakahara M, Furue M., A Case of Atrophic Dermatofibroma Overexpressing Matrix Metalloproteinase-1., Case Rep Dermatol. , 11(3):264-267., 2019.10.
28. Yano-Takamori A, Tsuji G, Nakahara T, Kido-Nakahara M, Furue M., A Case of Atrophic Dermatofibroma Overexpressing Matrix Metalloproteinase-1. , Case Rep Dermatol, doi: 10.1159/000503136, 2019.10.
29. Ulzii D, Kido-Nakahara M, Nakahara T, Tsuji G, Furue K, Hashimoto-Hachiya A, Furue M. , Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes., Int J Mol Sci., doi: 10.3390/ijms20133324., 2019.07.
30. Masutaka Furue, Dugarmaa Ulzii, Yen Hai Vu, Gaku Tsuji, Makiko Kido-Nakahara, Takeshi Nakahara, Pathogenesis of Atopic Dermatitis: Current Paradigm , Iran J Immunol ., 16(2):97-107. , 2019.06.
31. Nakahara T, Konishi S, Yasukochi Y, Esaki H, Tsuji G, Kido-Nakahara M, Furue M., Thrombocytopenia in a psoriatic patient sequentially treated with adalimumab, secukinumab and ustekinumab., J Dermatol. , doi: 10.1111/1346-8138.14681., 46, 5, 157-158, 2019.05.
32. Maehara E, Kido-Nakahara M, Ito T, Uchi H, Furue M., Darier's sign in urticaria pigmentosa-significance of perivascular eosinophilic infiltration., Allergol Int., doi: 10.1016/j.alit.2018.04.006., 67, 4, 532-534, 2019.05.
33. Take N, Nakahara T, Kido-Nakahara M, Furue M., Three cases of adult-onset atopic dermatitis after hematopoietic stem cell transplantation., Allergol Int., doi: 10.1016/j.alit.2018.04.002., 67, 4, 529-531, 2019.05.
34. Furue K, Yamamura K, Tsuji G, Mitoma C, Uchi H, Nakahara T, Kido-Nakahara M, Kadono T, Furue M., Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis., Acta Derm Venereol. , doi: 10.2340/00015555-2808., 98, 1, 5-13, 2019.05.
35. Shiratori-Hayashi M, Hasegawa A, Toyonaga H, Andoh T, Nakahara T, Kido-Nakahara M, Furue M, Kuraishi Y, Inoue K, Dong X, Tsuda M., Role of P2X3 receptors in scratching behavior in mouse models., J Allergy Clin Immunol., doi: 10.1016/j.jaci.2018.10.053., 143, 3, 1252-1243, 2019.03.
36. Kido-Nakahara M, Nakahara T, Furusyo N, Shimoda S, Kotoh K, Kato M, Hayashi J, Koyanagi T, Furue M., Pruritus in Chronic Liver Disease: A Questionnaire Survey on 216 Patients., Acta Derm Venereol. , doi: 10.2340/00015555-3064. , 99, 2, 220-221, 2019.02.
37. Kido-Nakahara M, Nakahara T, Furusyo N, Shimoda S, Kotoh K, Kato M, Hayashi J, Koyanagi T, Furue M., Pruritus in Chronic Liver Disease: A Questionnaire Survey on 216 Patients. , Acta Derm Venereol., 99(2):220-221., 2019.02.
38. Ohno F, Nakahara T, Kido-Nakahara M, Ito T, Nunomura S, Izuhara K, Furue M., Periostin Links Skin Inflammation to Melanoma Progression in Humans and Mice., Int J Mol Sci., doi: 10.3390/ijms20010169., 20, 1, 2019.01.
39. Nakahara T, Kido-Nakahara M, Ohno F, Ulzii D, Chiba T, Tsuji G, Furue M., The pruritogenic mediator endothelin-1 shifts the dendritic cell-T-cell response toward Th17/Th1 polarization., Allergy. , 2018.02.
40. Furue M, Yamamura K, Kido-Nakahara M, Nakahara T, Fukui Y., Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis., Allergy. , doi: 10.1111/all.13239. , 73, 1, 29-36, 2018.01.
41. Sagata N, Kato TA, Kano SI, Ohgidani M, Shimokawa N, Sato-Kasai M, Hayakawa K, Kuwano N, Wilson AM, Ishizuka K, Kato S, Nakahara T, Nakahara-Kido M, Setoyama D, Sakai Y, Ohga S, Furue M, Sawa A, Kanba S., Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study., Sci Rep., doi: 10.1038/s41598-017-14440-7., 7, 1, 2017.10.
42. Yumi Yasukochi, Makiko Kido-Nakahara, Takeshi Nakahara, Rie Kuroki, Tetsuya Koga, Mashino Toshihiko, Yuichi Kurihara, Masutaka Furue, Clinical bandings of Patient-Oriented Eczema Measure (POEM) scores among Japanese atopic eczema patients., Br J Dermatol., 2017.04.
43. Miki Uryu, Makiko Kido-Nakahara, Takeshi Nakahara, Takahiro Chiba, Masutaka Furue, Epidermal p16INK4a expression is more frequently and intensely upregulated in lichen planus than in eczema, psoriasis, drug eruption and graft-versus-host disease., J Dermatol., 44, 343-344, 2017.03.
44. Kazuhiko Yamamura, Takehito Uruno, 白石 暁, Yoshihiko Tanaka, 牛島 美保, Takeshi Nakahara, Mayuki Watanabe, Makiko Kido-Nakahara, Ikuya Tsuge, Masutaka Furue, Yoshinori Fukui, The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction., Nat Commun. , 9, 8, 13946, 2017.01.
45. Takeshi Nakahara, Oba J, Shimomura C, Makiko Kido-Nakahara, Masutaka Furue, Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression., J Invest Dermatol., 10.1038/jid.2015.359, 2016.05.
46. Takeshi Nakahara, Oba J, Shimomura C, Makiko Kido-Nakahara, Masutaka Furue, Early Tumor-Infiltrating Dendritic Cells Change their Characteristics Drastically in Association with Murine Melanoma Progression., J Invest Dermatol., 136, 146-153, 2016.01.
47. Makiko Kido-Nakahara, Aktar MK, Masutaka Furue, Takeshi Nakahara, Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis., 70, 846-854, 2015.05.
48. Takei K, Chikage Mitoma, Hashimoto-Hachiya A, Uchi Hiroshi, Masakazu Takahara, Gaku Tsuji, Makiko Kido-Nakahara, Takeshi Nakahara, Masutaka Furue, Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor., J Dermatol., 42, 2, 171-180, 2015.02.
49. Makiko Kido-Nakahara, Katoh N, Saeki H, Mizutani H, Akihito Hagihara, Satoshi Takeuchi, Takeshi Nakahara, Masuda K, Tamagawa-Mineoka R, Nakagawa H,, Omoto Y, Matsubara K, Masutaka Furue, Comparative Cut-off Value Setting of Pruritus Intensity in Visual Analogue Scale and Verbal Rating Scale. , Acta Derm Venereol, 95 (3), 345-346, 2015.01.
50. 40. Khudishta MA, Makiko Kido-Nakahara, Masutaka Furue, Takeshi Nakahara, Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis., Allergy, doi: 10.1111/all.12633, 2015.01.
51. Takeshi Nakahara, Yoichi Moroi, KOICHI TAKAYAMA, Itoh E, Makiko Kido-Nakahara, Yoichi Nakanishi, Masutaka Furue, Changes in sebum levels and the development of acneiform rash in patients with non-small cell lung cancer after treatment with EGFR inhibitors., Onco Targets Ther, 28, 8, 259-263, 2015.01.
52. Makiko Kido-Nakahara, Jörg Buddenkotte, Cordula Kempkes, Akihiko Ikoma, Ferda Cevikbas, Tasuku Akiyama, Frank Nunes, Stephan Seeliger, Burcu Hasdemir, Christian Mess, Timo Buhl, Mathias Sulk, Frank-Ulrich Müller, Dieter Metze, Nigel W. Bunnett, Aditi Bhargava, Earl Carstens, Masutaka Furue, Martin Steinhoff, Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus., J Clin Invest, doi: 10.1172/JCI67323, 2014.05, エンドセリン変換酵素(ECE-1)によるエンドセリン(ET-1)の痒みに対する影響を検討した。ET-1,ETAR,ECE-1のmRNAやタンパクはマウス後根神経節(DRG)細胞や皮膚末梢神経に発現していた。マウスDRG細胞へのET-1刺激後に、ETARは細胞表面からECE-1を含むエンドゾーム内に移動し、その後細胞表面へ戻ったが、ECE-1阻害薬によりこのETARの受容体リサイクリングは阻害された。また、マウスDRG細胞でのET-1刺激によるERK1/2の活性化は、ECE-1阻害により持続延長した。そして、ET-1皮内注射後のマウスの掻破行動はECE-1阻害薬により増強したのに対し、ERK1/2阻害薬投与ではその掻破行動は消失した。さらに、ヒトの皮膚にイオントフォレーシスを用いてET-1を投与すると、ヒスタミン非依存性のかゆみが生じ、免疫染色では慢性痒疹患者の表皮や皮膚末梢神経でのET-1、ETAR、ECE-1の発現増強が確認された。.
53. Chikage Mitoma, Takeshi Nakahara, Uchi Hiroshi, Takamichi Ito, Inatomi Y, Ide T, Jinnai S, Jinnai N, Iwasaki N, Sakamoto K, Kimura N, Maeda A, Kuma Y, Maehara E, Tsutsumi M, Makiko Kido-Nakahara, Hirota T, Tamari M, Masutaka Furue, Preferential expression of OVOL1 in inner root sheath of hair, sebaceous gland, eccrine duct and their neoplasms in human skin., Fukuoka Igaku Zasshi, 105, 8, 166-173, 2014.01.
54. Doi K, Chikage Mitoma, Takeshi Nakahara, Uchi Hiroshi, Hashimoto-Hachiya A, Masakazu Takahara, Gaku Tsuji, Makiko Kido-Nakahara, Masutaka Furue, Antioxidant Houttuynia cordata extract upregulates filaggrin expression in an aryl hydrocarbon-dependent manner, Fukuoka Igaku Zasshi., 105, 11, 205-213, 2014.01.
55. Yasukochi Y, Takeshi Nakahara, Abe T, Makiko Kido-Nakahara, FUTOSHI KOHDA, Satoshi Takeuchi, Akihito Hagihara, Masutaka Furue, Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments., Asian Pac J Allergy Immunol. , 32, 3, 240-245, 2014.01.
56. Takeuchi S, Saeki H, Tokunaga S, Sugaya M, Ohmatsu H, Tsunemi Y, Torii H, Nakamura K, Kawakami T, Soma Y, Gyotoku E, Hide M, Sasaki R, Ohya Y, Kido M, Furue M, A randomized, open-label, multicenter trial of topical tacrolimus for the treatment of pruritis in patients with atopic dermatitis, Ann Dermatol, 24, 144, 2012.02.
57. Kido M, Takeuchi S, Sugiyama N, Esaki H, Nakashima H, Yoshida H, Furue M:, T cell-specific overexpression of interleukin-27 receptor α subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice, Br J Dermatol, 164, 1214-1220, 2011.06.
58. Oba J, Nakahara T, Hayashida S, Kido M, Xie L, Takahara M, Uchi H, Miyazaki S, Abe T, Hagihara A, Moroi Y, Furue M, Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma. , . J Am Acad Dermatol, 2011.06.
59. Shpacovitch VM, Feld M, Holzinger D, Kido M, Hollenberg MD, Levi-Schaffer F, Vergnolle N, Ludwig S, Roth J, Luger T, Steinhoff :, Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-γ on human neutrophils and monocytes., Immunology, 133, 329-339, 2011.03.
60. Kido M, Takeuchi S, Esaki H, Hayashida S, Furue M, Scratching behavior does not necessarily correlate with epidermal nerve fiber sprouting or inflammatory cell infiltration. , 2010.08.
61. Hayashida S, Furusho N, Uchi H, Miyazaki S, Eiraku K, Gondo C, Tsuji G, Hachisuka J, Fukagawa S, Kido M, Nakahara T, Moroi Y, Hayashi J, Hagihara A, Furue M, Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis, J Dermatol Sci., 60, 173-8, 2010.03.
62. Lining X, Uchi H, Hayashida S, Tsuji G, Kido M, Nakahara T, Takeuchi S, Takahara M, Moroi Y, Furue M, : Expression of hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha with progression of keratinocytic neoplasms. , J Dermatol Sci, 2009.02.
63. Chen SY, Takeuchi S, Moroi Y, Kido M, Hayashida S, Qian Y, Tomoeda H, Uenotsuchi T, Urabe K, Furue M, Tu YT, Significance of cyclin D1-, product of retinoblastoma (pRb), p53, p63 and p73 expression in eccrine poroma and eccrine porocarcinoma, J Dermatol Sci, 56, 69-72, 2009.01.
64. Fukiwake N, Furusyo N, Kubo N, Takeoka H, Toyoda K, Morita K, Shibata S, Nakahara T, Kido M, Hayashida S, Moroi Y, Urabe K, Hayashi J, Furue M., Incidence of atopic dermatitis in nursery school children - a follow-up study from 2001 to 2004, Kyushu University Ishigaki Atopic Dermatitis Study (KIDS)., Eur J Dermatol. , 16(4):416-9, 2006.08.